Cost Effective Supplement

Study

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review. – Cost Effective Supplements

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.

Quick navigation

http://www.ncbi.nlm.nih.gov/pubmed/22551330

Conclusion of this study

Serenoa repens therapy does not improve LUTS or Q(max ) compared with placebo in men with BPH, even at double and triple the usual dose. • Adverse events were generally mild and comparable to placebo.

Supplements analyzed in this study

Saw Palmetto

Health conditions analyzed in this study

Enlarged Prostate (BPH)


Slightly Positive
Saw Palmetto

Functions related to this study

Men's health


Slightly Positive
Saw Palmetto

Body systems related to this study


Reproductive System
Saw Palmetto
Scroll to top